Atlas Trials

A Phase I/II of HRS-6719 in Patients With Advanced/Metastatic Solid Tumors

Clinical trial NCT06922357 · RECRUITING

Trial details

NCT number
NCT06922357
Sponsor
Shandong Suncadia Medicine Co., Ltd.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Advanced/Metastatic Solid Tumors
Start date
2025-04-24
Primary completion
2027-12-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.